Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

著者: Paul G. Corn, Elisabeth I. Heath, Amado J. Zurita, Naveen Ramesh, Lianchun Xiao, Emi Sei, Elsa M. Li-Ning-Tapia, Shi‐Ming Tu, Sumit K. Subudhi, Jennifer Wang, Xuemei Wang, Eleni Efstathiou, Timothy C. Thompson, Patricia Troncoso, Nicholas E. Navin, Christopher J. Logothetis, Ana M. Aparicio - The Lancet 2019 被引用: 202